![Study Results & Research Projects Study Results & Research Projects](https://webarchive.library.unt.edu/eot2008/20090131030634im_/http://ntp-server.niehs.nih.gov/images/template/subMastHead_studyResults.gif)
Summaries & Associations of Study Results
Summaries & Associations of Study Results
Home » Study Results & Research Projects » Summaries & Associations of Study Results » TR-193 Reserpine
CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
---|---|---|---|---|
RESERPINE 50-55-5 |
05/01/79 | ANTIHYPERTENSIVE DRUG | Dosed-Feed 0,5,10 PPM/50 PER GROUP | Southern Research Institute |
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
MR: POSITIVE | ADRENAL GLAND MEDULLA: PHEOCHROMOCYTOMA | |||
FR: NEGATIVE | ||||
MM: POSITIVE | SEMINAL VESICLE (CARCINOMA) | |||
FM: POSITIVE | MAMMARY GLAND (FIBROADENOMA, ADENOCARCINOMA, ADENOSQUAMOUS CARCINOMA) |
Web page last updated on February 10, 2006
The National Institute of Environmental Health Sciences is one of the National Institutes of Health within the U.S. Department of Health and Human Services. The National Toxicology Program is headquartered on the NIEHS campus in Research Triangle Park, NC.